Medulloblastoma

Displaying 1 - 9 of 9CSV
Katsushima, K., Joshi, K., Yuan, M., Romero, B., Batish, M., Stapleton, S., Jallo, G., Kolanthai, E., Seal, S., Saulnier, O., Taylor, M. D., Wechsler-Reya, R. J., Eberhart, C. G., & Perera, R. J. (2024). A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma. Cell Reports, 43(3), 113938. https://doi.org/10.1016/j.celrep.2024.113938
Publication Date
Gold, M. P., Ong, W., Masteller, A. M., Ghasemi, D. R., Galindo, J. A., Park, N. R., Huynh, N. C., Donde, A., Pister, V., Saurez, R. A., Vladoiu, M. C., Hwang, G. H., Eisemann, T., Donovan, L. K., Walker, A. D., Benetatos, J., Dufour, C., Garzia, L., Segal, R. A., … Fraenkel, E. (2024). Developmental basis of SHH medulloblastoma heterogeneity. Nature Communications, 15(1). https://doi.org/10.1038/s41467-023-44300-0
Publication Date
Yuan, M., Mahmud, I., Katsushima, K., Joshi, K., Saulnier, O., Pokhrel, R., Lee, B., Liyanage, W., Kunhiraman, H., Stapleton, S., Gonzalez-Gomez, I., Kannan, R. M., Eisemann, T., Kolanthai, E., Seal, S., Garrett, T. J., Abbasi, S., Bockley, K., Hanes, J., … Perera, R. J. (2023). miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4. Acta Neuropathologica Communications, 11(1). https://doi.org/10.1186/s40478-023-01684-w
Publication Date
Cocito, C., Martin, B., Giantini-Larsen, A. M., Valcarce-Aspegren, M., Souweidane, M. M., Szalontay, L., Dahmane, N., & Greenfield, J. P. (2023). Leptomeningeal dissemination in pediatric brain tumors. Neoplasia, 39, 100898. https://doi.org/10.1016/j.neo.2023.100898
Publication Date
Katsushima, K., Pokhrel, R., Mahmud, I., Yuan, M., Murad, R., Baral, P., Zhou, R., Chapagain, P., Garrett, T., Stapleton, S., Jallo, G., Bettegowda, C., Raabe, E., Wechsler-Reya, R. J., Eberhart, C. G., & Perera, R. J. (2023). The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas. Acta Neuropathologica Communications, 11(1). https://doi.org/10.1186/s40478-023-01521-0
Publication Date
Kuzuoglu-Ozturk, D., Aksoy, O., Schmidt, C., Lea, R., Larson, J. D., Phelps, R. R. L., Nasholm, N., Holt, M., Contreras, A., Huang, M., Wong-Michalak, S., Shao, H., Wechsler-Reya, R., Phillips, J. J., Gestwicki, J. E., Ruggero, D., & Weiss, W. A. (2022). N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. Cancer Research, 83(1), 130–140. https://doi.org/10.1158/0008-5472.can-22-0945
Publication Date
Cooney, T., Lindsay, H., Leary, S., & Wechsler-Reya, R. (2023). Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group. Neoplasia, 35, 100861. https://doi.org/10.1016/j.neo.2022.100861
Publication Date
Kameda-Smith, M. M., Zhu, H., Luo, E.-C., Suk, Y., Xella, A., Yee, B., Chokshi, C., Xing, S., Tan, F., Fox, R. G., Adile, A. A., Bakhshinyan, D., Brown, K., Gwynne, W. D., Subapanditha, M., Miletic, P., Picard, D., Burns, I., Moffat, J., … Singh, S. K. (2022). Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-35118-3
Publication Date